PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-May-2021 Results of Biomarck Phase II Study of BIO-11006 in Patients with ARDS to be Presented at the 2021 ATS Annual Meeting Businesswire
12-May-2021 Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook Businesswire
12-May-2021 Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine Businesswire
12-May-2021 Labcorp Announces Proposed Sale of Senior Notes Businesswire
12-May-2021 Xontogeny Announces Launch of Several New Early-Stage Portfolio Companies Businesswire
12-May-2021 Xontogeny Announces Launch of Several New Early-Stage Portfolio Companies Businesswire
12-May-2021 Xilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium Businesswire
12-May-2021 Immunome Reports First Quarter 2021 Financial Results Businesswire
12-May-2021 Global Salicylic Acid Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com Businesswire
12-May-2021 Global Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology 2021-2025, with 30+ Company Profiles - ResearchAndMarkets.com Businesswire
12-May-2021 ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement Businesswire
12-May-2021 Nemysis Ltd Announces Grant of First Chinese Patent for IHAT Newswire
12-May-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-May-2021 Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market Businesswire
11-May-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Skillz Inc. f/k/a Flying Eagle Acquisition Corp. (SKLZ) on Behalf of Investors Businesswire
11-May-2021 CORRECTING and REPLACING Former FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board Businesswire
11-May-2021 Business and Policy Leaders Sign Letter to President Biden Urging U.S. Leadership to Speed Global Vaccination Effort Businesswire
11-May-2021 NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets Businesswire
11-May-2021 Ipsen Opts-in to Join Exelixis With Ongoing Development of Cabometyx® for People Living With a Form of Thyroid Cancer, Based on Promising Interim Results Businesswire
11-May-2021 Ipsen exerce son option de licence et rejoint Exelixis dans le développement de Cabometyx® pour les patients atteints de cancer de la thyroïde, sur la base de résultats intermédiaires prometteurs Businesswire